Expansion of Melanoma-specific Cytolytic CD8(+) T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34(+) Progenitor-derived Dendritic Cells

Cancer vaccines aim at inducing (a) tumor-specific effector T cells able to reduce/eliminate the tumor mass, and (b) long-lasting tumor-specific memory T cells able to control tumor relapse. We have shown earlier, in 18 human histocompatibility leukocyte antigen (HLA)-A*0201 patients with metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Paczesny, Sophie, Banchereau, Jacques, Wittkowski, Knut M., Saracino, Giovanna, Fay, Joseph, Palucka, A. Karolina
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211788/
https://www.ncbi.nlm.nih.gov/pubmed/15173207
http://dx.doi.org/10.1084/jem.20032118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211788/
https://www.ncbi.nlm.nih.gov/pubmed/15173207
http://dx.doi.org/10.1084/jem.20032118

Ejemplares similares